The PharmEasy Date Will Be Updated Soon .
PharmEasy is a consumer-facing healthcare website that provides access to online prescription drugs, diagnostic procedures, and medical consultations. In 2015, Dharmil Sheth and Dr. Dhaval Shah launched this business. This company’s business is handled by its parent company, API Holdings Limited.
Start your investing journey today. How do you open your own demat account for free?
Bidding Dates
Coming Soon
Price Range
₹0 per share
Face Value
₹0 per share
GMP
₹0
PharmEasy GMP
The PharmEasy IPO GMP is ₹[].
IPO Overview
To all stakeholders, PharmEasy offers a value proposition. The business provides services to 87,194 pharmacies, 3,261 wholesalers, 4,617 clinics and doctors who write prescriptions, and 926 hospitals. Twenty-five million individuals have signed up for the online marketplace.
PharmEasy views its supply chain as a resource and concentrates on providing real-time visibility into the demand trends and precise supply of the company’s healthcare partners. The company also offers delivery estimates for incoming orders and a live, dynamic snapshot of its logistics network. The business estimates delivery times using data from various parts of the physical supply chain.
PharmEasy IPO Financials
| Financial year | Total Assets in Millions | Total Revenue in Millions | Profit After Tax in Millions |
| FY 2021 | 49,053.44 | 29,809 | 6,410 |
| FY 2020 | 5,724.75 | 10,840 | 3,350 |
PharmEasy Peer Comparison
| Name of Company | Revenue |
| Netmeds | $ 10.2 millions |
| 1mg | $ 6.5 millions |
| Practo | $ 16.5 millions |
Company Profile
PharmEasy aims to raise Rs. 6,250 crores through an initial public offering (IPO). The company is in talks with its bankers to conduct pre-IPO fundraising through private placement for a total amount of Rs. 1250 crores. This will significantly bring down the main issue size. PharmEasy is an online healthcare platform that provides consumers access to medicines, diagnostic tests, and consultations with doctors. The company was founded in 2015 by Dharmil Sheth and Dr. Dhaval Shah. API Holdings Limited, the parent company, manages the operations of this firm. The PharmEasy platform offers digital tools and health information.
It also provides teleconsultation services, diagnostic tests and treatment protocols, including products and devices. This helps API Holdings reach a wide range of shareholders in the country. Moreover, the company plans to go public and list its shares on the stock exchange, pending approval from SEBI.
IPO Strenghts
- Experienced promoters and a competent management team.
- Well-established relationships with a loyal customer base.
- Access to markets worldwide, enabling global reach.
IPO Weakness
- Heavy reliance on customers based in the United States.
- Need to adhere to multiple laws and regulations in these countries to ensure compliance.
- Competition from other players in the market.
